A number of prospective observational studies have shown that the quality and/or activity of circulating Lp-PLA2 are related to the risk of CAVD (Ballantyne et al., 2004; Tsimikas et al., 2009). The gene discussed is PLA2G7; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.